结核病疫苗治疗市场规模、份额、成长分析（按疫苗类型、按治疗类型、按最终用户、按年龄组、按地区）- 行业预测，2025 年至 2032 年

2023 年全球结核病疫苗治疗市场规模为 5 亿美元，预计将从 2024 年的 5.2 亿美元成长到 2032 年的 7.2 亿美元，预测期间（2025-2032 年）的复合年增长率为 4.1%。

随着结核病病率的上升以及公众对其认识的不断提高，结核病疫苗治疗市场正在经历显着增长。随着患者人数的增加，对有效预防方法的需求也随之成长，尤其是疫苗。教育活动和政府主导的公共卫生宣传活动对于提高人们对结核病的认识、强调其相关风险以及疫苗接种的益处至关重要。此外，医疗基础设施的进步提高了诊断能力和疫苗接种服务的可近性，促进了结核病的早期发现和介入。这些因素共同使结核病疫苗治疗成为全球卫生领域的重要组成部分，推动了市场强劲的需求。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 案例研究

结核病疫苗治疗市场规模（依疫苗类型及复合年增长率）（2025-2032）

• 市场概览
• BCG
• 重组
• 减毒活疫苗
• 惰性

结核病疫苗治疗市场规模（依治疗类型及复合年增长率）（2025-2032）

• 市场概览
• 预防
• 治疗

结核病疫苗治疗市场规模（依最终用户和复合年增长率） (2025-2032)

• 市场概览
• 医院
• 诊所
• 研究机构
• 其他的

结核病疫苗治疗市场规模（依年龄组别划分）及复合年增长率（2025-2032）

• 市场概览
• 孩子们
• 成人

结核病疫苗治疗市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益同比对比（2022-2024 年）

主要企业简介

• Xykon
• Merck and Co
• Pfizer
• Aeras
• Antabio
• KNCV Tuberculosis Foundation
• Inovio Pharmaceuticals
• Bavarian Nordic
• Bill and Melinda Gates Foundation
• Vaxart
• Serum Institute of India
• Emergent BioSolutions
• GlaxoSmithKline

结论和建议

Global Tuberculosis Vaccine Treatment Market size was valued at USD 0.5 billion in 2023 and is poised to grow from USD 0.52 billion in 2024 to USD 0.72 billion by 2032, growing at a CAGR of 4.1% during the forecast period (2025-2032).

The tuberculosis vaccine treatment market is experiencing significant growth due to the increasing prevalence of tuberculosis and the heightened awareness surrounding the disease. As more cases emerge, the demand for effective prevention methods, particularly vaccines, is intensifying. Educational initiatives and government-led public health campaigns are pivotal in raising awareness about tuberculosis, emphasizing the risks associated with it and the benefits of vaccination. Furthermore, advancements in healthcare infrastructure are improving diagnostic capabilities and the accessibility of vaccination services, facilitating early detection and intervention for tuberculosis. Collectively, these factors are driving robust demand in the market, positioning tuberculosis vaccine treatments as a crucial element in the global health landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Tuberculosis Vaccine Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Tuberculosis Vaccine Treatment Market Segments Analysis

Global Tuberculosis Vaccine Treatment Market is segmented by Vaccine Type, Treatment Type, End-User, Age Group and region. Based on Vaccine Type, the market is segmented into BCG, Recombinant, Live Attenuated and Inactivated. Based on Treatment Type, the market is segmented into Preventive and Therapeutic. Based on End-User, the market is segmented into Hospitals, Clinics, Research Institutes and Others. Based on Age Group, the market is segmented into Pediatric and Adult. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Tuberculosis Vaccine Treatment Market

The rise in awareness surrounding tuberculosis treatments plays a crucial role in driving the global tuberculosis vaccine treatment market. As public knowledge of TB risks and the significance of vaccination grows, it fosters greater acceptance and demand for vaccines. Health education initiatives and outreach efforts contribute to a better understanding of prevention methods, encouraging timely immunization. This heightened awareness supports government initiatives and financial backing, ultimately leading to improved vaccine coverage. Such developments are particularly vital in regions heavily burdened by TB, where effective control measures are essential to combat the disease and boost the tuberculosis vaccine market's growth.

Restraints in the Global Tuberculosis Vaccine Treatment Market

The Global Tuberculosis Vaccine Treatment market faces significant challenges due to the limited effectiveness of the BCG vaccine in preventing pulmonary tuberculosis, particularly in adolescents and adults. While the BCG vaccine is effective against severe forms of TB in young children, its efficacy diminishes with age and offers inconsistent protection in the adult population. This reduced effectiveness leads to a decline in confidence and demand for the vaccine, highlighting a crucial need for innovative and enhanced vaccine options. Consequently, this limitation hampers market growth and complicates global efforts to control and manage tuberculosis effectively.

Market Trends of the Global Tuberculosis Vaccine Treatment Market

The global tuberculosis vaccine treatment market is witnessing a transformative trend centered around the development of novel vaccines that aim to address the limitations of the traditional BCG vaccine. As researchers explore innovative methodologies-including live attenuated, subunit, viral-vectored, and mRNA vaccine approaches-there is a growing emphasis on enhancing efficacy against both active and latent TB, as well as drug-resistant strains. Advances in genetic engineering and immunology are facilitating this clinical progress, fostering optimism for the emergence of more effective and long-lasting TB vaccines in the coming years, thereby reshaping strategies for tuberculosis prevention and control worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Case Studies

Global Tuberculosis Vaccine Treatment Market Size by Vaccine Type & CAGR (2025-2032)

• Market Overview
• BCG
• Recombinant
• Live Attenuated
• Inactivated

Global Tuberculosis Vaccine Treatment Market Size by Treatment Type & CAGR (2025-2032)

• Market Overview
• Preventive
• Therapeutic

Global Tuberculosis Vaccine Treatment Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Clinics
• Research Institutes
• Others

Global Tuberculosis Vaccine Treatment Market Size by Age Group & CAGR (2025-2032)

• Market Overview
• Pediatric
• Adult

Global Tuberculosis Vaccine Treatment Market Size & CAGR (2025-2032)

• North America (Vaccine Type, Treatment Type, End-User, Age Group)
  • US
  • Canada
• Europe (Vaccine Type, Treatment Type, End-User, Age Group)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Vaccine Type, Treatment Type, End-User, Age Group)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Vaccine Type, Treatment Type, End-User, Age Group)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Vaccine Type, Treatment Type, End-User, Age Group)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Xykon
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck and Co
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aeras
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Antabio
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KNCV Tuberculosis Foundation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inovio Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bavarian Nordic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bill and Melinda Gates Foundation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vaxart
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Serum Institute of India
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emergent BioSolutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations